TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination

Xuefei Zhu,Jingwei Xue,Xing Jiang,Yamin Gong,Congwen Gao,Ting Cao,Qian Li,Lulu Bai,Yuwei Li,Gaixia Xu,Bin Peng,Xingzhi Xu

DOI: https://doi.org/10.1093/nar/gkac011

IF: 14.9

2022-01-20

Nucleic Acids Research

Abstract:Abstract Expression of the E3 ligase TRIM21 is increased in a broad spectrum of cancers; however, the functionally relevant molecular pathway targeted by TRIM21 overexpression remains largely unknown. Here, we show that TRIM21 directly interacts with and ubiquitinates CLASPIN, a mediator for ATR-dependent CHK1 activation. TRIM21-mediated K63-linked ubiquitination of CLASPIN counteracts the K6-linked ubiquitination of CLASPIN which is essential for its interaction with TIPIN and subsequent chromatin loading. We further show that overexpression of TRIM21, but not a TRIM21 catalytically inactive mutant, compromises CHK1 activation, leading to replication fork instability and tumorigenesis. Our findings demonstrate that TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination, providing a potential target for cancer therapy.

biochemistry & molecular biology